期刊文献+

DNA甲基化调控K562细胞系kir3dl1基因表达 被引量:4

DNA Methylation Regulates Kir3dl1 Gene Expression in K562 Cell Line
下载PDF
导出
摘要 为分析kir3dl1基因启动子区的甲基化模式及其与基因表达的关系,探讨kir3dl1基因的表达调控机制,采用亚硫酸氢盐测序法检测K562细胞中kir3dl1基因启动子区的甲基化状况,应用甲基化抑制剂5-氮胞苷处理K562细胞以诱导CpG岛去甲基化,观察启动子区CpG岛甲基化与kir3dl1基因表达的关系。结果显示:K562细胞中kir3dl1基因核心启动子区CpG二核苷酸甲基化频率在20%-100%之间;K562细胞中kir3dl1基因启动子序列在转录因子E2F可能的结合位点上存在1个碱基的突变,并形成1个新的被甲基化的CpG二核苷酸;应用甲基化抑制剂5-氮胞苷可以诱导不表达kir3dl1基因的K562细胞重新表达该基因。结论:K562细胞中kir3dl1基因表达受启动子甲基化调控,对转录因子E2F的深入研究有助于了解其在kir3dl1基因表达调控中可能的作用。 To analyze the methylation pattern of kir3dl1 promoter and its relationship with gene expression, and to study the possible regulation mechanism of kir3dl1 gene expression, the methylation status of kir3dl1 promoter in K562 cell line was detected by bisulfite sequencing technique. Then K562 cells were treated with 5-azacytidine so as to induce demethylation of CpG island, and the relationship of CpG island methylation with kir3dl1 gene expression was investigated. The results demonstrated that CpG dinucleotides surrounding core promoter region of kir3dl1 gene was methylated at a frequency of 20% to 100% in K562 cell line. Comparison of promoter sequence with GenBank database revealed a base substitution within a putative binding site for the transcription factor E2F in K562 cell line. This mutation forms a new methylation site in kir3dl1 promoter. DNA-demethylating treatment resulted in de novo expression of kir3dl1 gene in formerly non-expressed K562 cell line. It is concluded that kir3dl1 expression in K562 cells is regulated by DNA methylation. Deeply to study E2F function contributes to profound understanding of its role in kir3dl1 gene expression regulation.
作者 高晓宁 于力
出处 《中国实验血液学杂志》 CAS CSCD 2008年第3期472-475,共4页 Journal of Experimental Hematology
基金 国家自然科学基金面上项目 编号30670898
关键词 kir3dl1基因 基因表达调控 DNA甲基化 K562细胞系 kir3dl1 gene gene expression regulation DNA methylation K562 cell line
  • 相关文献

参考文献12

  • 1Husain Z, Alper CA, Yunis E J, et al. Complex expression of natural killer receptor genes in single natural killer ceils. Immunology, 2002; 106:373-380.
  • 2Marsh SG, Parham P, Dupont B, et al. Killer-cell immunoglobulinlike receptor ( kir ) nomenclature report, 2002. Eur J Immunogenet, 2003; 30:229-234.
  • 3高晓宁(综述),于力(审校).NK细胞KIR基因表达调控机制研究进展[J].国际输血及血液学杂志,2007,30(2):157-159. 被引量:4
  • 4高晓宁,于力.kir3dl1启动子表达调控载体的构建及其在K562细胞中的活性[J].中国实验血液学杂志,2008,16(2):258-262. 被引量:1
  • 5Frommer M, McDonald LE, Millar DS, et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Nati Acad Sci USA, 1992; 89:1827 - 1831.
  • 6Thompson A, van-der-Slik AR, Koning F, et al. An improved RTPCR method for the detection of killer-cell immunoglobulin-like receptor (kir) transcerpts. Immunogenetics, 2006; 58:865-872.
  • 7Santourlidis S, Trompeter HI, Weinhold S, et al. Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK ceils. J Immunol, 2002; 169 : 4253 - 4261.
  • 8Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes. J Mol Biol, 1987; 196:261 -282.
  • 9Stewart CA, Van-Bergen J, Trowsdale J. Different and divergent regulation of the kir2DL4 and kir3dll promoters. J Immunol, 2003; 170:6073-6081.
  • 10Presnell SR, Zhang L, Ramilo CA, et al. Functional redundancy of transcription factor-binding sites in the killer cell Ig-like receptor (kir) gene promoter. Int Immunol, 2006; 18:1221-1232.

二级参考文献30

  • 1高晓宁(综述),于力(审校).NK细胞KIR基因表达调控机制研究进展[J].国际输血及血液学杂志,2007,30(2):157-159. 被引量:4
  • 2Hsu KC, Chida S, Dupont B, et al. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order,haplotypes and allelic polymorphism. Immunol Rev, 2002, 190:40-52.
  • 3Yawata M, Yawata N, Draghi M, et al. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med, 2006, 203(3): 633-645.
  • 4Young NT. Immunobiology of Natural Killer Lymphocytes in Transplantation. Transplantation, 2004, 78 (1) : 1- 6.
  • 5Watzl C, Long EO. Natural killer cell inhibitory receptors block actin cytoskeleton-dependent recruitment of 2B4 (CD244) to lipid rafts. J ExpMed, 2003, 197(1): 77-85.
  • 6Miller JS, McCullar V. Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2Aand KIR2DL2/L3/S2. Blood, 2001, 98(3): 705-713.
  • 7Belkin D, Torkar M, Chang C, et al. Killer cell Ig like receptor and leukocyte Ig-like receptor transgenic mice exhibit tissue- and cell-specific transgene expression. J Immunol, 2003, 171 (6) :3056-3063.
  • 8Doucey MA, Scarpellino L, Zimmer J, et al. Cis association of Ly49A with MHC class I restricts natural killer cell inhibition.Nat Immunol, 2004, 5(3): 328-336.
  • 9Shilling HG, Young N, Guethlein LA, et al. Genetic control of human NK cell repertoire. J Immunol, 2002, 169(1): 239-247.
  • 10van Bergen J, Stewart CA, van den Elsen PJ, et al. Structural and functional differences between the promoters of independently expressed killer cell Ig-like receptors. Eur J Immunol, 2005, 35(7): 2191-2199.

共引文献3

同被引文献43

  • 1高晓宁(综述),于力(审校).NK细胞KIR基因表达调控机制研究进展[J].国际输血及血液学杂志,2007,30(2):157-159. 被引量:4
  • 2Xu J, Vallejo AN, Jiang Y, et al. Distinct transcriptional control mechanisms of killer immunoglobulin-like receptors in natural killer (NK) and in T cells. J Biol Chem, 2005,280:24277-24285.
  • 3Yawata M, Yawata N, Draghi M, et al. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med, 2006, 203:633-645.
  • 4Bethge WA, Haegele M, Faul C, et al. Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: fast engraftment and low toxicity. Exp Hematol, 2006, 34:1746-1752.
  • 5Ruggeri L, Capanni M, Casucci M, et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood, 1999, 94:553-339.
  • 6Ruggeri L, Mancusi A, Burchielli E, et al. Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation. Semin Cancer Biol, 2006, 16:404411.
  • 7Ruggeri L, Mancusi A, Capanni M, et al. Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. Blood, 2007, 110:433-440.
  • 8Thompson A, van der Slik AR, Koning F, et al. An improved RT-PCR method for the detection of killer-cell immunoglobulinlike receptor (KIR) transcripts, hnmunogenetics, 2006, 58: 865 -872.
  • 9Dimova DK, Dyson NJ. The E2F transcriptional network: old acquaintances with new faces. Oncogene, 2005, 24:2810-2826.
  • 10Campanero MR, Armstrong MI, Flemington EK. CpG methylation as a mechanism for the regulation of E2F activity. Proc Natl Acad Sci U S A, 2000, 97:6481-6486.

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部